Target intelligence / Profile preview

Protein N-terminal amino group (null)

Target
null
Molecular classification
Other (chemical group on proteins/polypeptides; not an enzyme, receptor, etc.)
01

Overview

The **protein N-terminal amino group** is the free amine group (-NH₂) located at the start (N-terminus) of a protein or polypeptide chain[1][3][5]. It is a universal feature of all translated proteins, typically derived from the first amino acid incorporated during translation, which in eukaryotes is usually methionine[1][3]. This group plays crucial roles in determining protein identity, function, stability, and fate within the cell. The N-terminal amino group can be modified post-translationally through acetylation, methylation, myristoylation, ubiquitination, and other processes, some of which have regulatory roles in protein function and degradation[2][3]. The specific identity or modification state of the N-terminal amino group can affect a protein's half-life (N-end rule), localization, and interactions, but the group itself is not a conventional drug target, enzyme, or receptor[1][2].

Other names
N-terminusamino-terminusNH₂-terminusN-terminal endamine-terminus
02

Mechanism of action

null

03

Biological functions

Protein synthesis initiation (site where polypeptide synthesis begins)Site for post-translational modification (such as acetylation, methylation, myristoylation, ubiquitination, etc.)Determinant of protein stability (involved in the N-end rule for protein degradation)

Beyond the preview

Go deeper on Protein N-terminal amino group (null).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Protein N-terminal amino group (null).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call